| 1. | Xu M, Real FX, Welt S, et al. Expression of TAG72 in normal colon, transitional mucosa, and colon cancer [J]. Int J Cancer, 1989; 44(6)∶985. | 
				                                                        
				                                                            
				                                                                | 2. | Werther JL, RiveraMacMurray S, Bruckner H, et al. Mucinassociated sialosylTn antigen expression in gastric cancer correlates with an adverse outcome [J]. Br J Cancer,1994; 69(3)∶613. | 
				                                                        
				                                                            
				                                                                | 3. | Kjeldsen T, Clausen H, Hirohashi S, et al. Preparation and characterization of monoclonal antibodies directed to the tumorassociated Olinked sialosyl26 alphaNacetylgalactosaminyl (sialosylTn) epitope [J]. Cancer Res,1988; 48(8)∶2214. | 
				                                                        
				                                                            
				                                                                | 4. | Hombach A, Heuser C, Sircar R, et al. T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibodylike specificity for a carbohydrate epitope [J]. Gastroenterology, 1997; 113(4)∶1163. | 
				                                                        
				                                                            
				                                                                | 5. | AlvarezVallina A, Hawkins RE. Antigenspecific targening of CD28 mediated T cell costimulation using chimeric singlechain antibody variable fragmentCD28 receptors [J]. Eur J Immunol,1996; 26(10)∶2304. | 
				                                                        
				                                                            
				                                                                | 6. | Hombach A, Wieczarkowiecz A, Marquardt T,et al. Tumorspecific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule [J]. J Immunol, 2001; 167(11)∶6123. | 
				                                                        
				                                                            
				                                                                | 7. | Hombach A, Sent D, Schneider C,et al. Tcell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptormediated Tcell proliferation but does not affect receptormediated target cell lysis [J]. Cancer Res,2001; 61(5)∶1976. |